221 related articles for article (PubMed ID: 20822320)
1. A comparative evaluation of in vitro skin sensitisation tests: the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA).
Ashikaga T; Sakaguchi H; Sono S; Kosaka N; Ishikawa M; Nukada Y; Miyazawa M; Ito Y; Nishiyama N; Itagaki H
Altern Lab Anim; 2010 Aug; 38(4):275-84. PubMed ID: 20822320
[TBL] [Abstract][Full Text] [Related]
2. The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test--human cell line activation test (h-CLAT).
Sakaguchi H; Ashikaga T; Miyazawa M; Kosaka N; Ito Y; Yoneyama K; Sono S; Itagaki H; Toyoda H; Suzuki H
Cell Biol Toxicol; 2009 Apr; 25(2):109-26. PubMed ID: 18204907
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of combinations of in vitro sensitization test descriptors for the artificial neural network-based risk assessment model of skin sensitization.
Hirota M; Fukui S; Okamoto K; Kurotani S; Imai N; Fujishiro M; Kyotani D; Kato Y; Kasahara T; Fujita M; Toyoda A; Sekiya D; Watanabe S; Seto H; Takenouchi O; Ashikaga T; Miyazawa M
J Appl Toxicol; 2015 Nov; 35(11):1333-47. PubMed ID: 25824844
[TBL] [Abstract][Full Text] [Related]
4. Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency.
Nukada Y; Ashikaga T; Miyazawa M; Hirota M; Sakaguchi H; Sasa H; Nishiyama N
Toxicol In Vitro; 2012 Oct; 26(7):1150-60. PubMed ID: 22796097
[TBL] [Abstract][Full Text] [Related]
5. Adaptation of the human Cell Line Activation Test (h-CLAT) to Animal-Product-Free Conditions.
Edwards A; Roscoe L; Longmore C; Bailey F; Sim B; Treasure C
ALTEX; 2018; 35(4):477-488. PubMed ID: 29901211
[TBL] [Abstract][Full Text] [Related]
6. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT.
Sakaguchi H; Ashikaga T; Miyazawa M; Yoshida Y; Ito Y; Yoneyama K; Hirota M; Itagaki H; Toyoda H; Suzuki H
Toxicol In Vitro; 2006 Aug; 20(5):774-84. PubMed ID: 16337770
[TBL] [Abstract][Full Text] [Related]
7. Predictive performance for human skin sensitizing potential of the human cell line activation test (h-CLAT).
Nukada Y; Ashikaga T; Sakaguchi H; Sono S; Mugita N; Hirota M; Miyazawa M; Ito Y; Sasa H; Nishiyama N
Contact Dermatitis; 2011 Dec; 65(6):343-53. PubMed ID: 21767275
[TBL] [Abstract][Full Text] [Related]
8. Predictive performance of the human Cell Line Activation Test (h-CLAT) for lipophilic chemicals with high octanol-water partition coefficients.
Takenouchi O; Miyazawa M; Saito K; Ashikaga T; Sakaguchi H
J Toxicol Sci; 2013; 38(4):599-609. PubMed ID: 23824015
[TBL] [Abstract][Full Text] [Related]
9. Prediction of preservative sensitization potential using surface marker CD86 and/or CD54 expression on human cell line, THP-1.
Sakaguchi H; Miyazawa M; Yoshida Y; Ito Y; Suzuki H
Arch Dermatol Res; 2007 Feb; 298(9):427-37. PubMed ID: 17119987
[TBL] [Abstract][Full Text] [Related]
10. Specificity of the local lymph node assay (LLNA) for skin sensitisation.
Roberts DW; Kimber I; Basketter DA
Regul Toxicol Pharmacol; 2023 Jun; 141():105402. PubMed ID: 37116738
[TBL] [Abstract][Full Text] [Related]
11. Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals.
Takenouchi O; Fukui S; Okamoto K; Kurotani S; Imai N; Fujishiro M; Kyotani D; Kato Y; Kasahara T; Fujita M; Toyoda A; Sekiya D; Watanabe S; Seto H; Hirota M; Ashikaga T; Miyazawa M
J Appl Toxicol; 2015 Nov; 35(11):1318-32. PubMed ID: 25820183
[TBL] [Abstract][Full Text] [Related]
12. Development of an
Tanabe I; Yoshida K; Ishikawa S; Ishimori K; Hashizume T; Yoshimoto T; Ashikaga T
Altern Lab Anim; 2023 Nov; 51(6):387-400. PubMed ID: 37796587
[TBL] [Abstract][Full Text] [Related]
13. In chemico, in vitro and in vivo comparison of the skin sensitizing potential of eight unsaturated and one saturated lipid compounds.
Kreiling R; Gehrke H; Broschard TH; Dreeßen B; Eigler D; Hart D; Höpflinger V; Kleber M; Kupny J; Li Q; Ungeheuer P; Sauer UG
Regul Toxicol Pharmacol; 2017 Nov; 90():262-276. PubMed ID: 28958912
[TBL] [Abstract][Full Text] [Related]
14. Improvement of human cell line activation test (h-CLAT) using short-time exposure methods for prevention of false-negative results.
Narita K; Ishii Y; Vo PTH; Nakagawa F; Ogata S; Yamashita K; Kojima H; Itagaki H
J Toxicol Sci; 2018; 43(3):229-240. PubMed ID: 29540657
[TBL] [Abstract][Full Text] [Related]
15. Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials.
Sakaguchi H; Ryan C; Ovigne JM; Schroeder KR; Ashikaga T
Toxicol In Vitro; 2010 Sep; 24(6):1810-20. PubMed ID: 20510347
[TBL] [Abstract][Full Text] [Related]
16. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.
Roberts DW; Api AM; Aptula AO
Regul Toxicol Pharmacol; 2016 Oct; 80():255-9. PubMed ID: 27470439
[TBL] [Abstract][Full Text] [Related]
17. Non-animal assessment of skin sensitization hazard: Is an integrated testing strategy needed, and if so what should be integrated?
Roberts DW; Patlewicz G
J Appl Toxicol; 2018 Jan; 38(1):41-50. PubMed ID: 28543848
[TBL] [Abstract][Full Text] [Related]
18. Comparison and validation of an in vitro skin sensitization strategy using a data set of 33 chemical references.
Clouet E; Kerdine-Römer S; Ferret PJ
Toxicol In Vitro; 2017 Dec; 45(Pt 3):374-385. PubMed ID: 28539215
[TBL] [Abstract][Full Text] [Related]
19. Chemical applicability domain of the local lymph node assay (LLNA) for skin sensitisation potency. Part 4. Quantitative correlation of LLNA potency with human potency.
Roberts DW; Api AM
Regul Toxicol Pharmacol; 2018 Jul; 96():76-84. PubMed ID: 29730445
[TBL] [Abstract][Full Text] [Related]
20. Binary test battery with KeratinoSens™ and h-CLAT as part of a bottom-up approach for skin sensitization hazard prediction.
Otsubo Y; Nishijo T; Miyazawa M; Saito K; Mizumachi H; Sakaguchi H
Regul Toxicol Pharmacol; 2017 Aug; 88():118-124. PubMed ID: 28602621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
